NICE technology appraisal guidance
Issued: December 2002
TA53
Guidance on the use of long-acting insulin analogues for the treatment of diabetes – insulin glargine
This is an extract from the guidance and may be misleading if read alone. The complete guidance is available at guidance.nice.org.uk/ta53
Important information about this guidance
The recommendations in this technology appraisal relating to type 2 diabetes have been replaced by recommendations in the Diabetes - type 2 (update) clinical guideline published in May 2008 (www.nice.org.uk/guidance/cg66). Please note that the recommendations in this technology appraisal relating to type 1 diabetes have not changed.